Aktis Oncology, Inc.
AKTS
$18.75
$0.030.16%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
1/14/2026
-
MarketBeat
4/28/2026
-
Seeking Alpha - Healthcare
4/28/2026
-
SeekingAlpha
4/28/2026
-
Seeking Alpha - Long Ideas
4/28/2026
-
MarketBeat
4/22/2026
-
TipRanks Financial Blog
4/22/2026
-
MarketBeat
4/21/2026
-
Globe Newswire
4/19/2026
-
Simply Wall St
4/17/2026
-
Zacks Investment Research
4/16/2026
-
TipRanks Financial Blog
4/16/2026
-
Globe Newswire
4/12/2026
-
Yahoo! Finance: News
4/12/2026
-
Insider Monkey
4/12/2026
-
Insider Monkey
4/6/2026
-
MarketBeat
4/3/2026
-
MarketBeat
4/3/2026
-
Ticker Report
4/2/2026
-
MarketBeat
4/1/2026
-
MarketBeat
3/31/2026
-
MarketBeat
3/30/2026
-
TipRanks Financial Blog
3/30/2026
-
TipRanks Financial Blog
3/30/2026
-
Globe Newswire
3/30/2026
-
MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Monday, March 30, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
End of March (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
--
Year to Date Total Return
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
617 461 4023
Address
17 Drydock Avenue
Boston, MA 02210
Boston, MA 02210
Country
Year Founded
Business Description
Sector
Aktis Oncology, Inc., a clinical-stage oncology company, engages in the research, development, and commercialization of targeted radiopharmaceuticals to treat various solid tumor cancers. The...
more